pI: 6.7034 |
Length (AA): 525 |
MW (Da): 58016 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 5 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
28 | 350 | 1lvw (A) | 1 | 289 | 16.00 | 0 | 1 | 0.75 | -0.15 |
56 | 147 | 1vh1 (A) | 19 | 116 | 17.00 | 0.000041 | 0.48 | 0.43 | -0.59 |
26 | 518 | 5b04 (E) | 37 | 447 | 33.00 | 0 | 1 | 0.932948 | 0.97 |
422 | 515 | 3twd (A) | 292 | 386 | 16.00 | 0.22 | 1 | 0.530548 | -1.24 |
481 | 525 | 1ssq (A) | 189 | 234 | 20.00 | 0.2 | 0.31 | 0.283214 | -0.09 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 60-80% percentile | VEG Tachyzoite, ME49 Tachyzoite, ME49 merozoite, ME49 Oocyst, ME49 Bradyzoite. | Gregory Hehl AB Fritz HM Sibley/Greg |
Fritz HM | Transcriptomic analysis of toxoplasma development reveals many novel functions and structures specific to sporozoites and oocysts. |
Gregory | ToxoDB |
Sibley/Greg | ToxoDB |
Hehl AB | Asexual expansion of Toxoplasma gondii merozoites is distinct from tachyzoites and entails expression of non-overlapping gene families to attach, invade, and replicate within feline enterocytes. |
Ortholog group members (OG5_128844)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT5G19485 | transferases/nucleotidyltransferases |
Babesia bovis | BBOV_II000340 | hypothetical protein |
Brugia malayi | Bm1_42560 | Nucleotidyl transferase family protein |
Candida albicans | CaO19.481 | similar to S. cerevisiae GCD1 (YOR260W) gamma subunit of eIF-2B, the guanine nucleotide exchange factor for translation initiati |
Candida albicans | CaO19.8111 | similar to S. cerevisiae GCD1 (YOR260W) gamma subunit of eIF-2B, the guanine nucleotide exchange factor for translation initiati |
Caenorhabditis elegans | CELE_C15F1.4 | Protein PPP-1 |
Caenorhabditis elegans | CELE_C15F1.3 | Protein TRA-2, isoform C |
Cryptosporidium hominis | Chro.80452 | hypothetical protein |
Cryptosporidium parvum | cgd8_3940 | eIF-2B gamma, eukaryotic translation initiation factor 2B subunit 3 that has a nucleotide diphospho sugar transferase at the N-t |
Dictyostelium discoideum | DDB_G0290693 | bacterial transferase hexapeptide repeat-containing protein |
Drosophila melanogaster | Dmel_CG8190 | CG8190 gene product from transcript CG8190-RA |
Echinococcus granulosus | EgrG_000671300 | DNA polymerase epsilon catalytic subunit |
Echinococcus multilocularis | EmuJ_000671300 | DNA polymerase epsilon catalytic subunit |
Homo sapiens | ENSG00000070785 | eukaryotic translation initiation factor 2B, subunit 3 gamma, 58kDa |
Loa Loa (eye worm) | LOAG_03140 | hypothetical protein |
Mus musculus | ENSMUSG00000028683 | eukaryotic translation initiation factor 2B, subunit 3 |
Neospora caninum | NCLIV_059920 | eukaryotic initiation factor-2B gamma subunit, putative |
Oryza sativa | 4340947 | Os06g0338900 |
Onchocerca volvulus | OVOC4928 |
|
Plasmodium berghei | PBANKA_1341600 | translation initiation factor eIF-2B subunit gamma, putative |
Plasmodium falciparum | PF3D7_1326400 | translation initiation factor eIF-2B subunit gamma, putative |
Plasmodium knowlesi | PKNH_1202200 | translation initiation factor eIF-2B subunit gamma, putative |
Plasmodium vivax | PVX_116557 | translation initiation factor EIF-2B gamma subunit, putative |
Plasmodium yoelii | PY05721 | hypothetical protein |
Plasmodium yoelii | PY05722 | hypothetical protein |
Saccharomyces cerevisiae | YOR260W | Gcd1p |
Schistosoma japonicum | Sjp_0213650 | ko:K03241 translation initiation factor eIF-2B gamma subunit, putative |
Toxoplasma gondii | TGME49_216260 | eukaryotic initiation factor-2B, gamma subunit, putative |
Theileria parva | TP01_0593 | hypothetical protein, conserved |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
CELE_C15F1.4 | Caenorhabditis elegans | embryonic lethal | wormbase |
CELE_C15F1.4 | Caenorhabditis elegans | larval arrest | wormbase |
CELE_C15F1.4 | Caenorhabditis elegans | larval lethal | wormbase |
CELE_C15F1.4 | Caenorhabditis elegans | slow growth | wormbase |
CELE_C15F1.4 | Caenorhabditis elegans | sterile | wormbase |
YOR260W | Saccharomyces cerevisiae | inviable | yeastgenome |
PBANKA_1341600 | Plasmodium berghei | Essential | plasmo |
TGME49_216260 this record | Toxoplasma gondii | Probably essential | sidik |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.